CA2463597A1 - Rosuvastatin in pre demented states - Google Patents
Rosuvastatin in pre demented states Download PDFInfo
- Publication number
- CA2463597A1 CA2463597A1 CA002463597A CA2463597A CA2463597A1 CA 2463597 A1 CA2463597 A1 CA 2463597A1 CA 002463597 A CA002463597 A CA 002463597A CA 2463597 A CA2463597 A CA 2463597A CA 2463597 A1 CA2463597 A1 CA 2463597A1
- Authority
- CA
- Canada
- Prior art keywords
- rosuvastatin
- dementia
- demented
- patient
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
| SE0103509-6 | 2001-10-19 | ||
| PCT/SE2002/001911 WO2003032995A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2463597A1 true CA2463597A1 (en) | 2003-04-24 |
Family
ID=20285721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002463597A Abandoned CA2463597A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060229321A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1446123A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005505605A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20040058201A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1604780A (cg-RX-API-DMAC7.html) |
| AR (1) | AR036891A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0213434A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2463597A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO5580773A2 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0401798A3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL161380A0 (cg-RX-API-DMAC7.html) |
| IS (1) | IS7218A (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04003631A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20041840L (cg-RX-API-DMAC7.html) |
| PL (1) | PL369573A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2004112422A (cg-RX-API-DMAC7.html) |
| SE (1) | SE0103509D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003032995A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200402844B (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2537271A1 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries, Ltd. | Process for preparation of rosuvastatin calcium |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| US7777034B2 (en) | 2003-11-24 | 2010-08-17 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
| CN1894221B (zh) | 2003-12-02 | 2012-08-08 | 特瓦制药工业有限公司 | 用于表征罗苏伐他汀的参照标准品 |
| US7179916B2 (en) | 2004-07-13 | 2007-02-20 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of rosuvastatin |
| CA2680693A1 (en) | 2005-02-22 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Preparation of rosuvastatin |
| WO2007022488A2 (en) | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
| WO2012073256A1 (en) | 2010-11-29 | 2012-06-07 | Cadila Healthcare Limited | Salts of rosuvastatin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US7189703B2 (en) * | 1998-01-09 | 2007-03-13 | Intracell, Llc | Treatment and diagnosis of alzheimer's disease |
| AR022462A1 (es) * | 1999-02-06 | 2002-09-04 | Astrazeneca Uk Ltd | Uso de un agente que disminuye el colesterol |
| US20030100493A1 (en) * | 2001-07-19 | 2003-05-29 | Sol Weiss | Sublingual use of inhibitors in the biosynthesis of cholesterol |
-
2001
- 2001-10-19 SE SE0103509A patent/SE0103509D0/xx unknown
-
2002
- 2002-10-17 AR ARP020103895A patent/AR036891A1/es not_active Application Discontinuation
- 2002-10-18 US US10/492,971 patent/US20060229321A1/en not_active Abandoned
- 2002-10-18 CA CA002463597A patent/CA2463597A1/en not_active Abandoned
- 2002-10-18 IL IL16138002A patent/IL161380A0/xx unknown
- 2002-10-18 PL PL02369573A patent/PL369573A1/xx not_active Application Discontinuation
- 2002-10-18 JP JP2003535798A patent/JP2005505605A/ja active Pending
- 2002-10-18 KR KR10-2004-7005585A patent/KR20040058201A/ko not_active Withdrawn
- 2002-10-18 BR BR0213434-9A patent/BR0213434A/pt not_active Application Discontinuation
- 2002-10-18 HU HU0401798A patent/HUP0401798A3/hu unknown
- 2002-10-18 CN CNA028253477A patent/CN1604780A/zh active Pending
- 2002-10-18 MX MXPA04003631A patent/MXPA04003631A/es not_active Application Discontinuation
- 2002-10-18 EP EP02783893A patent/EP1446123A1/en not_active Withdrawn
- 2002-10-18 WO PCT/SE2002/001911 patent/WO2003032995A1/en not_active Ceased
- 2002-10-18 RU RU2004112422/14A patent/RU2004112422A/ru not_active Application Discontinuation
-
2004
- 2004-04-13 IS IS7218A patent/IS7218A/is unknown
- 2004-04-15 ZA ZA200402844A patent/ZA200402844B/en unknown
- 2004-04-19 CO CO04035705A patent/CO5580773A2/es not_active Application Discontinuation
- 2004-05-05 NO NO20041840A patent/NO20041840L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003032995A1 (en) | 2003-04-24 |
| PL369573A1 (en) | 2005-05-02 |
| CO5580773A2 (es) | 2005-11-30 |
| KR20040058201A (ko) | 2004-07-03 |
| BR0213434A (pt) | 2004-11-09 |
| ZA200402844B (en) | 2005-01-24 |
| HUP0401798A3 (en) | 2005-06-28 |
| RU2004112422A (ru) | 2005-04-10 |
| US20060229321A1 (en) | 2006-10-12 |
| WO2003032995A8 (en) | 2004-06-03 |
| NO20041840L (no) | 2004-05-05 |
| AR036891A1 (es) | 2004-10-13 |
| EP1446123A1 (en) | 2004-08-18 |
| HUP0401798A2 (hu) | 2005-01-28 |
| MXPA04003631A (es) | 2004-07-30 |
| SE0103509D0 (sv) | 2001-10-19 |
| CN1604780A (zh) | 2005-04-06 |
| IS7218A (is) | 2004-04-13 |
| JP2005505605A (ja) | 2005-02-24 |
| IL161380A0 (en) | 2004-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2305118T3 (es) | Uso de rosuvastatina (zd-4522) en el tratamiento de hipercolesteremia familiar heterocigota. | |
| EP0671171A1 (en) | Use of HMG COA reductase inhibitor for the manufacture of a medicament for proventing or reducing risks of onset of cardiovascular events | |
| US20010049388A1 (en) | Cholesterol-lowering therapy | |
| JP2001517617A (ja) | 神経変性疾患の治療を目的としてａｐｏｅレベルを増加させる方法 | |
| Jacobson | Overcoming ‘ageism’bias in the treatment of hypercholesterolaemia: a review of safety issues with statins in the elderly | |
| Singh et al. | Insights into the pivotal role of statins and its nanoformulations in hyperlipidemia | |
| US20060229321A1 (en) | Rosuvastatin in pre demented states | |
| US20080242732A1 (en) | Liver selective drug therapy | |
| Mallhi et al. | Chloroquine and hydroxychloroquine in COVID-19: practice implications for healthcare professionals | |
| Gardner et al. | Combination therapy with low‐dose lovastatin and niacin is as effective as higher‐dose lovastatin | |
| WO1999009967A2 (en) | Cholesterol-lowering therapy | |
| TW202310842A (zh) | 高強度他汀弱反應物之治療 | |
| RU2316341C2 (ru) | Применение атазанавира в терапии вич-инфекции | |
| AU2002332610A1 (en) | Use of atazanavir in HIV therapy | |
| WO2022006392A1 (en) | Novel pharmaceutical compositions | |
| AU2002347698A1 (en) | Rosuvastatin in pre demented states | |
| Kurata et al. | Cerivastatin induces carotid artery plaque stabilization independently of cholesterol lowering in patients with hypercholesterolaemia | |
| MX2012005513A (es) | Pemirolast para el tratamiento de inflamacion sistemica de bajo grado. | |
| JP4187141B2 (ja) | 新規なトロンボモジュリン発現促進剤 | |
| JPWO2014034871A1 (ja) | 脂質異常症の予防又は治療薬 | |
| Herd et al. | Acute confusional state with postoperative intravenous cefazolin | |
| Unzurrunzaga et al. | Moxifloxacin-induced seizures in an epileptic patient | |
| Lovinger et al. | Topiramate, a concealed cause of severe metabolic acidosis | |
| Moore | Successful treatment with colesevelam HCl and pravastatin in a patient previously hospitalised with severe normal CPK myopathy on introduction of simvastatin | |
| KR20070030182A (ko) | (+)-에리트로-메플로퀸의 약제학적 조성물 및 그것의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20061018 |